What does the glycosylated hemoglobin test measure?

Choice A reason: Stage 1 pressure ulcers present with intact skin showing non-blanchable redness, typically over bony prominences, due to localized ischemia from sustained pressure. No skin loss or blistering occurs, as the epidermis remains intact, indicating early tissue stress without ulceration. This does not match the described blister and skin loss, making it incorrect.

Choice B reason: Stage 4 pressure ulcers involve full-thickness tissue loss, exposing underlying structures like muscle, bone, or tendons. Severe necrosis and deep tissue damage occur due to prolonged pressure, disrupting blood supply extensively. The described superficial skin loss with a blister does not involve such deep structures, ruling out Stage 4.

Choice C reason: Stage 3 pressure ulcers feature full-thickness skin loss, extending into subcutaneous tissue but not to muscle or bone. They may show undermining or tunneling due to tissue necrosis. The described blister with top-layer skin loss suggests partial-thickness damage, not deep enough for Stage 3, making this choice incorrect.

Choice D reason: Stage 2 pressure ulcers involve partial-thickness skin loss, affecting the epidermis and possibly dermis, often appearing as a shallow ulcer or fluid-filled blister. The blister and loss of the top skin layer described indicate damage beyond redness but not full-thickness, aligning perfectly with Stage 2 characteristics, making this the correct choice.

Choice A reason: Graves’ disease, a form of hyperthyroidism, does not typically cause decreased calcium. It may lead to hypercalcemia due to increased bone resorption from elevated thyroid hormone levels, which enhance osteoclast activity, making decreased calcium an incorrect laboratory finding for this condition.

Choice B reason: Graves’ disease is characterized by increased thyroid hormone production, including elevated T4 due to autoimmune stimulation of the thyroid. Decreased T4 is associated with hypothyroidism, not hyperthyroidism, making this choice incorrect as it contradicts the pathophysiology of Graves’ disease.

Choice C reason: Increased TSH is seen in primary hypothyroidism, where the thyroid is underactive. In Graves’ disease, TSH is typically decreased due to negative feedback from elevated thyroid hormones (T3 and T4), making this choice incorrect for the expected laboratory profile.

Choice D reason: Graves’ disease causes hyperthyroidism, with increased production of thyroid hormones, including T3, due to autoantibodies stimulating TSH receptors. Elevated T3 levels drive metabolic symptoms like weight loss and tachycardia, making this the correct laboratory finding for Graves’ disease.